Table 1.
Baseline patient characteristics.
| Trials | Year | Numbers (CABG/PCI) (n) | Ages (years) | Males (%) | Outcomes | Follow-up (year) | References |
|---|---|---|---|---|---|---|---|
| ARTS | 2001 | 96/112 | 62.6/62.4 | 148 (71.12%) | a, b, c, d | 1 | (39) |
| BARI 2D | 2009 | 378/798 | Not applicable | Not applicable | a, e | 5 | (40) |
| FREEDOM | 2014 | 277/325 | 61.9 ± 9.2/63.2 ± 9.2 | 369 (61.30%) | a, b, d, f | 1,5 | (41) |
| FREEDOM Follow-On | 2019 | 947/953 | 63.3 | 1356 (71.37%) | a | 8 | (42) |
| MASS II | 2013 | 80/64 | 59 ± 8/61 ± 9 | 128 (88.89%) | a, e | 10 | (43) |
| SYNTAX | 2013 | 221/231 | 65.4 ± 9.2 | 321 (71.02%) | a, b, d, e, f | 5 | (44) |
| VACARDS | 2013 | 97/101 | 62.1 ± 7.4/62.7 ± 7.1 | 196 (98.99%) | a, b | 1,2 | (45) |
a, all-cause mortality; b, myocardial infarction; c, cerebralvascular accident; d, repeat revascularazition; e, cardiac mortality; f, stroke.